BCL2L1 and diabetes mellitus: Therefore, manipulation of the splice factor, transcription factor, and signaling pathways that modulate this splicing event is fast emerging as a therapeutic avenue in the treatment of cancer and diabetes; however, further research is required to investigate whether Bcl-x splicing can be modulated in a cell/tissue-specific manner.